{"organizations": [], "uuid": "ab3170651cec0be8ff3b37b12579909ce70b1712", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/personal-finance/analyst-research", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "https://www.reuters.com/article/brief-nestl-skin-health-announces-fda-ap/brief-nestl-skin-health-announces-fda-approval-of-restylane-lyft-for-correction-of-age-related-volume-loss-in-back-of-hands-idUSASC0A31F", "country": "US", "domain_rank": 408, "title": "Nestlé Skin Health Announces FDA Approval Of Restylane Lyft For Correction Of Age-Related Volume Loss In Back Of Hands", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.642, "site_type": "news", "published": "2018-05-21T21:08:00.000+03:00", "replies_count": 0, "uuid": "ab3170651cec0be8ff3b37b12579909ce70b1712"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-nestl-skin-health-announces-fda-ap/brief-nestl-skin-health-announces-fda-approval-of-restylane-lyft-for-correction-of-age-related-volume-loss-in-back-of-hands-idUSASC0A31F", "ord_in_thread": 0, "title": "Nestlé Skin Health Announces FDA Approval Of Restylane Lyft For Correction Of Age-Related Volume Loss In Back Of Hands", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "nestle sa", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "fda approval of restylane lyft", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 21 (Reuters) - Nestle SA:\n* NESTLÉ SKIN HEALTH ANNOUNCES THE FDA APPROVAL OF RESTYLANE® LYFT FOR HANDS, THE FIRST AND ONLY HYALURONIC ACID (HA) DERMAL FILLER FOR USE IN THE BACK OF HANDS\n* NESTLÉ SKIN HEALTH - U.S. FDA APPROVED RESTYLANE LYFT FOR CORRECTION OF AGE-RELATED VOLUME LOSS IN BACK OF HANDS FOR PATIENTS OVER AGE OF 21 Source text for Eikon: ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-21T21:08:00.000+03:00", "crawled": "2018-05-21T16:13:28.007+03:00", "highlightTitle": ""}